|
KIAA0226 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.15536527198901E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56139545737233E-11 |
| Normal-vs-Stage2 |
1.820280E-02 |
| Normal-vs-Stage3 |
3.07549999911672E-08 |
| Normal-vs-Stage4 |
3.35130000417294E-08 |
| Stage1-vs-Stage2 |
1.240010E-02 |
| Stage1-vs-Stage3 |
6.298600E-01 |
| Stage1-vs-Stage4 |
8.199800E-02 |
| Stage2-vs-Stage3 |
3.963500E-02 |
| Stage2-vs-Stage4 |
1.478970E-03 |
| Stage3-vs-Stage4 |
5.494100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.98292510084275E-12 |
| Normal-vs-AfricanAmerican |
2.02639999999921E-05 |
| Normal-vs-Asian |
1.28219999995238E-06 |
| Caucasian-vs-AfricanAmerican |
4.011400E-01 |
| Caucasian-vs-Asian |
7.345600E-01 |
| AfricanAmerican-vs-Asian |
6.076600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.50579995536771E-09 |
| Normal-vs-Female |
2.77490252997836E-11 |
| Male-vs-Female |
6.688000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.83739698403451E-12 |
| Normal-vs-Age(41-60Yrs) |
9.29999999232933E-09 |
| Normal-vs-Age(61-80Yrs) |
4.04769999995391E-06 |
| Normal-vs-Age(81-100Yrs) |
6.617800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.101500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.833800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.735810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.560200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.544600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.513600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.807400E-01 |
| Classical-VS-Follicular |
1.69775304925679E-12 |
| Classical-VS-Other |
2.584000E-01 |
| Classical-VS-Normal |
1.62714286489063E-12 |
| Tall-VS-Follicular |
6.42429999975214E-07 |
| Tall-VS-Other |
1.831240E-01 |
| Tall-VS-Normal |
1.25660000005468E-06 |
| Follicular-VS-Other |
1.782820E-01 |
| Follicular-VS-Normal |
2.853000E-01 |
| Other-VS-Normal |
2.982200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.23560000020851E-07 |
| Normal-vs-N1 |
4.86250000042432E-07 |
| N0-vs-N1 |
1.088570E-01 |
|
|
